Classes Flashcards
H2-receptor antagonists
- block histamine receptors in stomach lining, suppressing gastric acid secretion
- prototype: raNITIdine (Zantac)
- onset: within 1 hr
- duration: 9-12 hr
proton pump inhibitors (PPIs)
- MOA: block exchange of H+ for K+, ↓ acid secretion
- onset: up to 4 days
- duration: 24 hr to 3 days
- greater suppression than H2 blockers
- prototype: omeprazole (Prilosec)
mucosal protectant
- MOA: changes to thick substance in acidic environment, adheres to ulcer to protect from acid, pepsin
- duration: up to 6 hr
- complication: constipation
- prototype: sucralfate (Carafate)
antacids
- MOA: neutralizes stomach acid
- onset: 5 min
- duration: 30-60 min
- aluminum and calcium: constipation
- magnesium: diarrhea
- prototypes
- aluminum hydroxide (Amphojel)
- calcium carbonate (Maalox, Tums, Rolaids)
- magnesium hydroxide (Phillips, Dulcolax)
Prostaglandin E analog
- MOA: mimics prostaglandin, inhibits acid secretion
- Pregnancy Risk Category X (termination)
- prototype: misoprostol (Cytotec)
- onset: 30 min
- duration: 3-6 hr
antiemetics
- glucocorticoid: dexamethasone (Decadron)
- substance P/neurokinin 1 antagonist: aprepitant (Emend)
- serotonin antagonist
- ondansetron (Zofran)
- granisetron (Kytril)
- dopamine antagonist
- promethazine (Phenergan)
- metoclopramide (Reglan)
- cannabinoid: dronabinal (Marinol)
- anticholinergic: scopolamine (Transderm Scop)
- antihistamine
- dimenhydrinate (Dramamine)
- hydroxyzine (Vistaril)
- benzodiazepine: lorazepam (Ativan)
osmotic laxatives
- MOA: draw water into intestines to stimulate BM
- indication: occasional constipation
- complications
- diarrhea
- toxic Mg levels
- dehydration
- caution: kidney impairment
- drugs
- polyethylene glycol 3350 (MiraLax, GlycoLax)
- magnesium hydroxide (Phillips, Dulcolax)
- lactulose
bulk-forming laxatives
- MOA: soften fecal mass, increase bulk (like dietary fiber)
- indications
- temp: constipation
- ↓ diarrhea (diverticulosis and IBS)
- stool control for ileostomy/colostomy
- complications: obstruction; drink plenty of water
- prototype: psyllium (Metamucil)
surfactant laxatives
- MOA: ↓ surface tension of stool, allow penetration of water
- prototype: docusate sodium (Colace)
- indications: constipation, softening of fecal impaction
stimulant laxatives
- MOA: stimulates peristalsis, ↑ volume of water and electrolytes in intestines
- indications: bowel prep (surgery, procedure)
- short-term Tx of constipation (high-dose opioid use)
- used inappropriately for wt loss, get good Hx
- drugs
- bisacodyl (Dulcolax)
- senna (Senokot)
antidiarrheals
- MOA: ↓ GI motility
- complications: constipation
- drugs
- diphenoxylate/atropine (Lomotil)
- loperamide (Imodium)
- paregoric (off market per Davis)
anti-IBS agents
- alosetron (Lotronex)
- MOA: antidiarrheal; blocks 5-HT3 receptors that innervate viscera
- complication: constipation
- lubiprostone (Amitiza)
- MOA: laxative; activates intestinal chloride channels, ↑ fluid secretion
- complication: diarrhea
beta2-adrenergic agonists
- bronchodilator
- inhaled/oral
- end with “terol”
- MOA: activate receptors in smooth muscle to relax, dilate airways; relieve bronchospasm, ↑ ciliary motility
- short-acting
- prototype: albuterol (Ventolin, Pro-Air)
- levalbuterol (Xopenex)
- long-acting
- salmeterol and formoterol
- for significant dz
- combined with short-acting and corticosteroid
- often prescribed together; LABA only for asthma not controlled by SABA alone
- corticosteroid/LABA combos: Advair, Symbicort, Dulera
short-acting beta2-adrenergic agonist
- SABA
- drugs: albuterol (Ventolin, Pro-Air), levalbuterol (Xopenex)
- onset: minutes
- duration: 2-4 hr
- often in combo with LABA for significant dz
long-acting beta2-adrenergic agonist
- LABA
- drugs: salmeterol (Serevent), formoterol
- onset: 10-25 min
- peak and T½: 3-4 hr
- duration: 12
- only used for significant dz
- available in combo with corticosteroid: Advair, Symbicort, Dulera
complications of beta2-adrenergic agonists
- tachycardia, angina
- monitor for
- chest, jaw, arm pain
- palpitations
- check pulse, notify of ↑ > 20-30 bpm
- avoid caffeine
- possible ↓ dose
- monitor for
- tremors: usually resolved with continued use
contraindications and precautions for beta2-adrenergic agonists
- pregnancy risk: C
- contra: tachydysrhythmia
- caution
- DM (↑ BG): effects usually transient and slight except with ↑ doses
- HTN
- hyperthyroid
- heart dz
- angina
interactions with beta2-adrenergic agonists
- ↑ risk of angina and tachycardia: MAOIs and TCAs
- beta blockers (metoprolol, propranolol): negates effects of both
administering beta2-adrenergic agonists
- pt education: use before using inhaled corticosteroid
- use SABA for acute episode
- LABAs
- Q12H
- NOT for acute attack
- always used with inhaled corticosteroid
- have pt return demonstrate
- follow manufacturer instructions
evaluation of effectiveness of SABAs and LABAs
- control of asthma
- improved Sx: clearing/improved breath sounds, ↓ wheezing and coughing, ↓ breathing effort
- pt able to exercise without dyspnea
anticholinergics
- prototype: ipratropium (Atrovent)
- end with “pium”
- oral/inhaled
- MOA: blocks muscarinic receptors of bronchi; bronchodilation
- uses: relieves COPD-related and allergen- and exercise-induced bronchospasm
- off-label: asthma Tx
complications of anticholinergics
- dry mouth, hoarseness: sip fluids, suck on sugar-free hard candy
- blurred vision
- ↑ IOP
- hot, flushed skin
- dry skin
- bradycardia → tachycardia, palpitations, aarhythmias
- urinary retention
- constipation
- rare: fever, confusion, mania, hallucinations, rashes
contraindicaitons and precautions for anticholinergics
- pregnancy: B
- contra: allergy to peanuts
- caution
- narrow-angle glaucoma
- benign prostatic hyperplasia
administering anticholinergics
- rinse mouth after use (bad taste
- wait 5 min between inhaled meds
methylxanthines
- prototype: theophylline
- end with “phylline”
- MOA: relax bronchial smooth muscle, bronchodilation
- oral, IV (emergency only)
- acts like caffeine
- for long-term control of chronic asthma, COPD
complications of methylxanthines
- mild toxicity: GI distress, restlessness
- severe adverse at higher dose
- dysrhythmias: lidocaine
- sz: diazepam
- serum monitoring required, narrow therapeutic range
glucocotricoids for respiratory disorders
- steroidal anti-inflammatory
- oral, inhaled, IV
- end with “one”
- prototypes
- beclomethasone (Qvar), inhaled
- prednisone
- inhaled, combo with LABAs
- budesonide
- fluticasone
- mometasone
- IV
- hydrocortisone
- methylprednisolone
uses for glucocorticoids in the Tx of respiratory disorders
- prevent inflammation
- suppress airway mucus production
- reduce airway edema
- inhaled: used as prophylaxis
- IV: short-term for status asthmaticus
- PO
- short-term: acute exacerbation
- long-term: severe asthma
complications of glucocorticoids
- inhaled
- difficulty speaking
- hoarseness
- oral candidiasis: rinse mouth after use, monitor for s/sx of infection and report
- ↓ production of glucocorticoids in adrenal gland: taper, do not stop abruptly
- bone loss
- hyperglycemia, glucosuria
- PUD: give with food, avoid NSAIDs, watch for GI bleed
- ↑ risk of infection
- wt/fluid gain
- increased hunger
contraindications and precautions of glucocorticoids
- pregnancy: C
- contra
- recent live virus vaccine
- systemic fungal infection
- caution
- children
- DM
- HTN
- heart failure
- PUD
- osteoporosis
- kidney dysfunction
interactions with glucocorticoids
- ↑ risk for hypokalemia with K+-depleting diuretics
- ↑ risk for ulceration with NSAIDs
- in DM: counteracts effects of meds, ↑ blood sugar
- may need higher dose of antidiabetics
administering glucorticoids
- pt education
- use on fixed schedule
- NOT for acute asthma episode
- use beta2-adrenergic first: bronchodilation → better absorption of glucocorticoid
- oral: for short-term use, 3-10 days after acute attack
- long-term therapy, switch to inhaled: ↑ dose during stress
leukotriene modifiers
- prototype: montelukast (Singulair)
- other: zileuton, zafirlukast
- MOA: ↓ inflammation, bronchoconstriction, edema, mucus
- long-term therapy of asthma in adults, children
- prevention of exercise-induced bronchospasm
complications of leukotriene modifiers
- depression, suicidal ideation: watch for changes, report
- liver injury (zileuton and zafirlukast): get baseline LFTs and monitor
precautions for leukotriene modifiers
- pregnancy: B
- liver dysfunction
interactions with leukotriene modifiers
- zileuton and zafirlukast
- ↑ levels of warfarin: monitor for s/sx of bleeding, PT, INR
- ↑ levels of theophylline: monitor level, educate about s/sx of toxicity (N&V, sz)
- montelukast: ↓ effects with phenytoin
administering leukotriene modifiers
- take as prescribed
- montelukast
- maintenance: daily HS
- prevention, exercise-induced: 2 hr before
opioid antitussives
- prototype: codeine
- other: hydrocodone
- MOA: acts on CNS to increase cough reflex threshold
- uses: ↓ frequency, intensity of chronic dry cough
complications of opioid antitussives
- dizziness
- lightheadedness
- drowsiness
- respiratory depression
- N&V: take with food
- constipation: ↑ fiber and fluid intake
nursing actions for opioid antitussives
- monitor VS for bradypnea (RR < 12)
- monitor ambulation, assist in and out of bed (fall risk)
- short-term use only, risk of abuse
contraindications and precautions for opioid antitussives
- pregnancy: C
- contra
- respiratory depression
- head trauma
- acute asthma
- liver and renal dysfunction
- acute ETOH disorder
- caution
- children
- older adults
- hx of substance abuse
pt education for opioid antitussives
- avoid activities requiring alertness
- lie down if dizzy
- get up slowly
- avoid ETOH, other CNS depressants
nonopioid antitussives
- prototype: dextromethorphan (Delsym, Robitussin)
- MOA: acts on CNS to suppress cough
- uses: cough suppression, ↑ pain reduction with opioid
- pregnancy: C
complications of nonopioid antitussives
- mild nause, dizziness, sedation
- at high dose: euphoria, risk for abuse
interactions with nonopioid antitussives
MAOI: life-threatening serotonin syndrome if taken within 2 wks